Join our daily newsletter At The Bell to receive exclusive market insights
- Assay results from Kin Mining’s (KIN) first deep diamond hole, completed at its Mount Flora project near Leonora in WA, have extended high grade mineralisation at depth
- Drilling at Mt Flora comprised two stages and an initial drilling program of 269 holes for 10,166 metres on 11 lines of drilling at 200-metre line spacings
- The company has reported assays of to 5.3 metres at 6.49 g/t gold, including 2.6 metres at 8.54 g/t gold from 188.3 metres
- The company has also identified a strong association with zones of anomalous tungsten-tellurium-sulphur mineralisation in east-dipping quartz veins and biotite alteration
- Shares last traded at 11 cents at previous close
Assays from Kin Mining’s (KIN) first diamond deep diamond drill hole, completed at its Mount Flora project near Leonora in Western Australia, have extended high-grade mineralisation at depth.
The company said drilling at Mt Flora comprised two stages and an initial drilling program of 269 holes for 10,166 metres on 11 lines of drilling at 200-metre line spacings
A diamond drillhole returned two high-grade intercepts beneath the newly defined East Zone, which the company says confirms the extent of the mineralisation to 150 metres vertical depth.
Assay results from this drill hole include 5.3 metres at 6.49 g/t gold and 2.6 metres at 8.84 g/t gold from the same 188.3 metres.
“Confirmation of the presence of a high-grade primary gold system beneath the air-core drilling is a significant development, providing further confidence in the potential of the emerging Mt Flora discovery,” KIN said in a statement to the market.
The company said the mineralisation encountered by the drilling represents a new
mineralised position in an area previously untested by drilling, indicating the potential for multiple parallel mineralised lodes.
Kin Mining also said it has identified strong association with zones of anomalous tungsten-tellurium-sulphur mineralisation in east-dipping quartz veins and biotite alteration.
Shares were trading at 11 cents at previous close on January 6.
